Joseph Bolen

Joseph Bolen has a vast experience in the pharmaceutical industry, holding positions such as Chief Science Innovation Officer at ReNAgade Therapeutics, Partner at MPM BioImpact, and Member R&D Subcommittee Board of Directors at PureTech Health. Prior to these roles, Bolen has also served as President R&D/Chief Scientific Officer at Moderna, Global Head Oncology Research at Takeda, and Chief Scientific Officer at MILLENNIUM PHARMACEUTICALS, INC. Joseph's experience also includes being the Founding Director Department of Signal Transduction at DNAX Research Institute of Molecular & Cellular Biology Inc, and Executive Director Oncology Research at Bristol Myers Squibb.